Skip to main content
Premium Trial:

Request an Annual Quote

ServiceXS To Use Illumina Platform for European Melanoma Genotyping Study

NEW YORK (GenomeWeb News) – ServiceXS, a genomics and proteomics services firm based in Leiden, the Netherlands, will perform a large-scale genome-wide association study for the European Union’s Melanoma Genetics Consortium, the company said Friday.
 
ServiceXS said it will use Ilumina’s Infinium multiplex technology to genotype 300,000 tag SNPs in 1,800 subjects for the GenoMEL study.
 
Candidate SNPs will be validated in a case-control study including 4,000 melanoma cases and 4,000 control individuals, the company said.
 
Financial terms of the agreement were not released.
 
Further information about the GenoMEL study is available here.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.